| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/19/2006 | CN1252065C Cinnoline compounds |
| 04/19/2006 | CN1252060C Sugarapple plant extract with action of resisting diabetes, medicinal application and preparation method |
| 04/19/2006 | CN1252058C Phenoxy indenone compounds, process for preparing same and use thereof |
| 04/19/2006 | CN1252057C Thiazole derivatives for treating PPAR related disorders |
| 04/19/2006 | CN1252055C Biphenyl carboxamides compounds |
| 04/19/2006 | CN1252054C Qinoline derivatives inhibiting effect of growth factors |
| 04/19/2006 | CN1252048C Process for the preparation of an enantiomerically enriched thio compound |
| 04/19/2006 | CN1252040C Novel aryl, alkenyl and alkynl 4-dedimethylamino tetracycline derivatives |
| 04/19/2006 | CN1251766C 肿瘤基因开关药物 Tumor gene switch drugs |
| 04/19/2006 | CN1251765C 肿瘤基因开关药物 Tumor gene switch drugs |
| 04/19/2006 | CN1251764C 肿瘤基因开关药物 Tumor gene switch drugs |
| 04/19/2006 | CN1251758C Use of derivatives of valproic acid and 2-valproenic acid amides for treatment of mania in bipolar disorder |
| 04/19/2006 | CN1251750C Health care fluid for nursing skin |
| 04/19/2006 | CN1251746C Ointment for curing burn |
| 04/19/2006 | CN1251744C Preparing process of Chinese medicinal pill and eye drops for treating myopia |
| 04/19/2006 | CN1251743C Prescription for treating duodenal ulcer and gastric ulcer |
| 04/19/2006 | CN1251741C Medicine for treating anemia and preparing method |
| 04/19/2006 | CN1251734C Sobering and liver protecting liquid product and its production method |
| 04/19/2006 | CN1251731C Chinese herbal medicine for treating intractable headache |
| 04/19/2006 | CN1251728C Medicine for treating diabets mellitus and preparing process thereof |
| 04/19/2006 | CN1251726C Ointment for treating osteoarticular tuberculosis, osteomyelitis and sterile thigh-bong necrosis |
| 04/19/2006 | CN1251711C External use anti-inflammatory and myogenic medicine of chinese medicine and its preparing method |
| 04/19/2006 | CN1251707C Application of Engally nut oil in the preparation of medicine for treating arthritis |
| 04/19/2006 | CN1251703C Soft capsule made of walnut oil for taking care of brain health |
| 04/19/2006 | CN1251701C Mammary gland lobular hyperplasia treating plaster and its preparing process |
| 04/19/2006 | CN1251700C Application of flatstem milkvetch seed and its extract in the preparation of anti hepatic fibrosis medicine and anticancer medicine |
| 04/19/2006 | CN1251697C Composition with functions of regulating immunity and resisting fatigue and its prepn, use and quality control method |
| 04/19/2006 | CN1251695C Pharmaceutical composition containing elegiline and ginkgo bioloba extract useful for dementia |
| 04/19/2006 | CN1251693C Chinese-western medicine compound preparation and its preparing method |
| 04/19/2006 | CN1251692C Strain of microorganism able to metabolizing daidzein to equol and its prodn. method for equol by using such strain of microorganism |
| 04/19/2006 | CN1251687C Medicinal composition for treationg virus infention of rlavivirus family, set group and packaged products |
| 04/19/2006 | CN1251684C Health care food for relaxing hypertension |
| 04/19/2006 | CN1251683C Method of quickly reducing viscosity of konjaku powder |
| 04/19/2006 | CN1251682C Medicine for treating infantile enterorrhea |
| 04/19/2006 | CN1251681C Highly concentration water-soluble vitamin for intravenous injection and preparation and use |
| 04/19/2006 | CN1251680C Compositions comprising cytosine derivatives for the treatment of cancer |
| 04/19/2006 | CN1251679C Nucleotide analog composition and synthesis method |
| 04/19/2006 | CN1251678C Medicinal composition and tuchahoe extract for raising immunity |
| 04/19/2006 | CN1251677C Anti-cancer assistant medicine contg. 20(S)-protopanaxadiol as effective component, and its application |
| 04/19/2006 | CN1251676C Phenyl xanthine derivative |
| 04/19/2006 | CN1251675C Powder injection of ginko and dipyridamole and its preparing method |
| 04/19/2006 | CN1251674C Medicinal compsn. for treating skin disease and preparation technique |
| 04/19/2006 | CN1251673C Controlled release preparation of captopril and its preparation process |
| 04/19/2006 | CN1251672C Volume-expansion protection agent and application in treating blood-loss shock |
| 04/19/2006 | CN1251671C Beta secretase inhibitors |
| 04/19/2006 | CN1251669C Acne removing and skin rejuvenating cream |
| 04/18/2006 | USRE39072 2-aminopropane-1,3-diol compounds, medicinal use thereof, and intermediates in synthesizing the same |
| 04/18/2006 | USRE39071 Anhydro-and isomer-a-21978c cyclic peptides |
| 04/18/2006 | USRE39069 Capable of delivering a first active agent in an outer lamina to one environment of use and a second active agent in the core to another environment of use; An erodible polymer coat between internal semipermeable membrane and a second active agent containing vinyl acetate-vinylpyrrolidone copolymer |
| 04/18/2006 | US7030252 Cyanation by converting the 5-formyl compound with hydroxylamine, dehydration to form antidepressant agents; chemical synthesis, salt formation, forming enantiomers; serotonin reuptake inhibitors for treating dementia and cerebrovascular disorders |
| 04/18/2006 | US7030251 Modifications of the trometamol salt of R-thioctic acid as well as a process for their production |
| 04/18/2006 | US7030246 Tetrahydroquinoline derivatives as stat6-modulators, preparation and use thereof |
| 04/18/2006 | US7030245 A chemical intermediate, toluene-4-sulfonic acid 7,8-dihydro-6H-5-oxa-1-aza-phenanthren-6-ylmethyl ester for preparing antidepressant, 6-[4-(5-fluoro-1H-indol-3-yl)-3,6-dihydro-2H-pyridin-1-ylmethyl]-7,8-dihydro-6H-5-oxa-1aza-phenanthrene; treating psychological disorders |
| 04/18/2006 | US7030242 Selective inhibition of aggrecanase in osteoarthritis treatment |
| 04/18/2006 | US7030240 Piperidinylamino-thieno[2,3-d] pyrimidine compounds |
| 04/18/2006 | US7030239 Compounds to treat Alzheimer's disease |
| 04/18/2006 | US7030238 C-nitroso compounds and use thereof |
| 04/18/2006 | US7030211 Antigenic peptides derived from telomerase |
| 04/18/2006 | US7030203 Water-in-oil emulsions with ethylene oxide groups, compositions, and methods |
| 04/18/2006 | US7030164 This invention relates to a highly thermally stable novel anhydrous crystalline polymorphic form of venlafaxine hydrochloride, methods for the preparation thereof, and its use. |
| 04/18/2006 | US7030162 Storage stabilized dosage |
| 04/18/2006 | US7030161 α-and β-amino acid hydroxyethylamino sulfonyl urea derivatives useful as retroviral protease inhibitors |
| 04/18/2006 | US7030160 An agonist as beta-3 adrenergic receptors; chemical intermediates preparing through decyclization, hydroxylation; for treating gastrointestinal diseases, obesity, diabetics, psychotropic agents, nervous system disorders |
| 04/18/2006 | US7030159 Antiinflammatory agents; prevent boactericide diffusion; using fatty acids |
| 04/18/2006 | US7030158 Therapeutic compounds |
| 04/18/2006 | US7030157 Hormone replacment therapy; anticancer agent; sexual disorders |
| 04/18/2006 | US7030154 Stability of lipoic acid |
| 04/18/2006 | US7030153 Including methylsulfonyl attachment, treating arthritis, with analgesic activity without erosion of the stomach, side effect reduction |
| 04/18/2006 | US7030152 Systematic inflammatory markers as diagnostic tools in the prevention of atherosclerotic diseases and as tools to aid in the selection of agents to be used for the prevention and treatment of atherosclerotic disease |
| 04/18/2006 | US7030151 Micronized amorphous form for better bioavailability; hypercholesterolemia, hyperlipidemia |
| 04/18/2006 | US7030150 Benzimidazole compounds and antiviral uses thereof |
| 04/18/2006 | US7030149 Combination of brimonidine timolol for topical ophthalmic use |
| 04/18/2006 | US7030148 Heterocyclic compounds having antibacterial activity: process for their preparation and pharmaceutical compositions containing them |
| 04/18/2006 | US7030147 Synergistic mixture; antiproliferative agents; side effect reduction |
| 04/18/2006 | US7030146 Methods for treating diabetic neuropathy |
| 04/18/2006 | US7030145 or anxiety; {3-[4-(2-Methoxybenzyloxy)-benzenesulfonyl]-6-methylpyridin-2-yl}-(4-methoxy-2-methylphenyl)-amine for example |
| 04/18/2006 | US7030144 Central nervous system disorders |
| 04/18/2006 | US7030143 Heterocyclic compounds |
| 04/18/2006 | US7030142 Methods for the treatment of neuroleptic and related disorders using ziprasidone metabolites |
| 04/18/2006 | US7030141 Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade |
| 04/18/2006 | US7030140 such as 1-[1-(N,N-dimethyl-aminoethyl)-1H-benzimidazol-2-ylmethyl]-1H-benzotriazole hydrochloride for treatment of respiratory syncytial virus |
| 04/18/2006 | US7030139 Compounds |
| 04/18/2006 | US7030138 Benzamidine derivatives |
| 04/18/2006 | US7030137 Substituted thiophenes with antibacterial activity |
| 04/18/2006 | US7030136 Administering phanquinone to the subject, optionally together with one or more pharmaceutically acceptable carriers for improving the learning or memory of a normal subject |
| 04/18/2006 | US7030135 A sulfonylamino-tetrahydro(1,3)thiazolo(5,4-c)pyridinyl or benzothiazole derivatives, for treating diabetes, syndrome X, obesity, glaucoma, hyperlipidemia, hyperglycemia, hyperinsulinemia, osteoporosis, tuberculosis, dementia |
| 04/18/2006 | US7030134 such as N-cyclopentyl-2-(4-fluorophenyl)-3-[2-(1-pyrrolidinyl)-4-pyrimidinyl]-6-(trifluoromethyl)pyrazolo[1,5-a]pyridin-7-amine; for treatment of herpes viral infections |
| 04/18/2006 | US7030133 Inhibitors of formation of advanced glycation endproducts (AGEs) |
| 04/18/2006 | US7030132 An inhibitor of breast cancer resistance protein (BCRP) is orally administered concomitantly with a pharmaceutical compound. |
| 04/18/2006 | US7030131 such as N-[4-(4-amino-1H-imidazol[4,5-c]quinolin-1-yl)butyl]-5-(dimethylamino)-naphthalenesulfonamide; for induction of biosynthesis of cytokines; immunomodulators; antineoplastic agents |
| 04/18/2006 | US7030130 Benzofuran derivatives and their use as antibacterial agents |
| 04/18/2006 | US7030129 Method of reducing and treating UVB-induced immunosuppression |
| 04/18/2006 | US7030128 Imidazo-pyrimidine derivatives as ligands for GABA receptors |
| 04/18/2006 | US7030127 Composition and medical devices utilizing bioabsorbable polymeric waxes |
| 04/18/2006 | US7030126 Use of polyamine analogs for amyotrophic lateral sclerosis |
| 04/18/2006 | US7030125 useful in the treatment of TGF- beta related disease states including, for example, cancer and fibrotic diseases |
| 04/18/2006 | US7030124 Method of treating depression with delta receptor agonist compounds |
| 04/18/2006 | US7030123 Indole derivatives with vascular damaging activity |
| 04/18/2006 | US7030122 1,4-disubstituted piperazine ligands for neurotransmitter receptors |
| 04/18/2006 | US7030121 Pyrazolopyrazine compound and pharmaceutical use thereof |